Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases-Reference-Cited by-同舟云学术

Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases

Published:2021-01-08 Issue:8 Volume:62 Page:1126-1132
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Fernández René,Eppard Elisabeth,Lehnert Wencke,Jiménez-Franco Luis David,Soza-Ried Cristian,Ceballos Matías,Ribbeck Jessica,Kluge Andreas,Rösch Frank,Meckel Marian,Zhernosekov Konstantin,Kramer Vasko,Amaral Horacio

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference38 articles.

1. Biology of bone metastases in prostate cancer;Hensel;Urology.,2016

2. Contemporary approaches for imaging skeletal metastasis;Ulmert;Bone Res.,2015

3. Treatment with 90Y- and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumors

4. Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer;Ahmadzadehfar;Oncotarget.,2016

5. 177Lu-EDTMP: A Viable Bone Pain Palliative in Skeletal Metastasis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Radiopharmaceutical Therapy for Bone Metastases;Seminars in Nuclear Medicine;2024-07

2. Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases;EJNMMI Research;2024-03-22

3. Theranostic Agent Targeting Bone Metastasis: A Novel [⁶⁸Ga]Ga/[¹⁷⁷Lu]Lu-DOTA-HBED-bisphosphonate;Journal of Medicinal Chemistry;2024-03-07

4. Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases;Nuclear Medicine and Biology;2024-03

5. From molecules to medicine: thiol selective bioconjugation in synthesis of diagnostic and therapeutic radiopharmaceuticals;Theranostics;2024